Sign in
Back
Integrated Infectious Disease and Substance Use Disorder Care for the Treatment of Injection Drug Use–Associated Infections: A Prospective Cohort Study With Historical Control
Journal article   Open access  Peer reviewed

Integrated Infectious Disease and Substance Use Disorder Care for the Treatment of Injection Drug Use–Associated Infections: A Prospective Cohort Study With Historical Control

David P Serota, Liza Rosenbloom, Belén Hervera, Grace Seo, Daniel J Feaster, Lisa R Metsch, Edward Suarez, Teresa A Chueng, Salma Hernandez, Allan E Rodriguez, …
Open forum infectious diseases, Vol.10(1), pp.ofac688-ofac688
2023-01-01
DOI: https://doi.org/10.1093/ofid/ofac688
PMID: 36632415
Appears in  Miller School of Medicine - Latest Publications

Abstract

AcademicSubjects buprenorphine Editor's Choice injection drug use injection-related infection Major MED00290 opioid use disorder substance use disorder
An integrated infectious disease/substance use disorder (SUD) team to treat injection-related bacterial and fungal infections was associated with a 45% decrease in readmission or death 90 days postdischarge. Additional benefits were demonstrated in antibiotic completion, SUD treatment, and patient-directed discharges.
url
https://doi.org/10.1093/ofid/ofac688View
Published (Version of record) Open

Metrics

3 Record Views

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types
Domestic collaboration
Citation topics
1 Clinical & Life Sciences
1.100 Substance Abuse
1.100.180 Methadone
Web Of Science research areas
Immunology
Infectious Diseases
Microbiology
ESI research areas
Immunology

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

Source: InCites

Details